WEKO3
アイテム
COVID-19感染症でみられる皮膚病変
https://tokushima-u.repo.nii.ac.jp/records/2011164
https://tokushima-u.repo.nii.ac.jp/records/2011164e8c285dc-e7e1-483f-b02a-c55de73170e3
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
sam_79_1-2_33.pdf (2.54 MB)
|
|
| Item type | 文献 / Documents(1) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2023-08-25 | |||||||||||
| アクセス権 | ||||||||||||
| アクセス権 | open access | |||||||||||
| 資源タイプ | ||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||
| 資源タイプ | journal article | |||||||||||
| 出版社版DOI | ||||||||||||
| 関連識別子 | https://doi.org/10.57444/shikokuactamedica.79.1.2_33 | |||||||||||
| 関連名称 | 10.57444/shikokuactamedica.79.1.2_33 | |||||||||||
| 出版タイプ | ||||||||||||
| 出版タイプ | VoR | |||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||
| タイトル | ||||||||||||
| タイトル | COVID-19感染症でみられる皮膚病変 | |||||||||||
| タイトル別表記 | ||||||||||||
| その他のタイトル | Cutaneous manifestations associated with COVID-19 | |||||||||||
| 著者 |
仁木, 真理子
× 仁木, 真理子× 久保, 宜明
WEKO
1539
|
|||||||||||
| 抄録 | ||||||||||||
| 内容記述 | Coronavirus disease 2019（COVID-19） is an infectious disease caused by the new coronavirus（SARS-CoV-2） that originated in China in December 2019, and it has been reported that it mainly causes respiratory symptoms but also exhibits various skin symptoms associated. The skin lesions are classified into six patterns represented by the acronym “GROUCH” : Generalized maculo- popular. Grover’s disease and other papulo-vesicular eruptions, livedo Reticularis, Other eruptions, Urticarial, and CHilblain-like. Patients with chilblain-like lesions were younger and had a lower incidence of systemic symptoms. Purpuric and livedoid lesions have been suggested to occur more frequently in elderly patients with severe COVID-19. COVID-19 often leaves sequelae that last weeks to months after initial recovery. It was estimated that 80％ of the infected patients developed one or more long-term symptoms. The five most common symptoms were fatigue（58％）, headache（44％）, attention disorder（27％）, hair loss（25％）, and dyspnea（24％）. A major cause of hair loss after COVID-19 is considered as telogen effluvium, defined by diffuse hair loss after the systemic stress or infections. Most patients with hair loss recovers within 6 months. Skin reactions have been reported after COVID-19 vaccination as well. The most reported cutaneous finding was a delayed large local reaction “COVID-arm” a median of 7 days after vaccine. The pathophysiological mechanism is still unknown, but it is overwhelmingly common in women, suggesting a cross-reaction between polyethylene glycol, a component of cosmetics, and injection components. In additions, there have been reports of skin rashes similar to those after COVID-19 infection and the aggravation of psoriasis or other skin conditions. The mechanism of the cutaneous manifestations is still unclear. We must remember to ask about a history of COVID-19 infection and vaccination status at the time of consultation. |
|||||||||||
| キーワード | ||||||||||||
| 主題 | COVID-19 | |||||||||||
| キーワード | ||||||||||||
| 主題 | GROUCH | |||||||||||
| キーワード | ||||||||||||
| 主題 | sequelae | |||||||||||
| キーワード | ||||||||||||
| 主題 | hair loss | |||||||||||
| キーワード | ||||||||||||
| 主題 | vaccine | |||||||||||
| 書誌情報 |
ja : 四国医学雑誌 en : Shikoku Acta Medica 巻 79, 号 1-2, p. 33-36, 発行日 2023-06-07 |
|||||||||||
| 収録物ID | ||||||||||||
| 収録物識別子タイプ | ISSN | |||||||||||
| 収録物識別子 | 27583279 | |||||||||||
| 出版者 | ||||||||||||
| 出版者 | 徳島医学会 | |||||||||||
| 言語 | ||||||||||||
| 言語 | jpn | |||||||||||
